Maity TK - Search Results

1

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance.

Maity TK, Kim EY, Cultraro CM, Venugopalan A, Khare L, Poddutoori R, Marappan S, Syed SD, Telford WG, Samajdar S, Ramachandra M, Guha U. Maity TK, et al. Cancers (Basel). 2023 Apr 12;15(8):2263. doi: 10.3390/cancers15082263. Cancers (Basel). 2023. PMID: 37190191 Free PMC article.

2

Distinct, gene-specific effect of heat shock on heat shock factor-1 recruitment and gene expression of CXC chemokine genes.

Maity TK, Henry MM, Tulapurkar ME, Shah NG, Hasday JD, Singh IS. Maity TK, et al. Cytokine. 2011 Apr;54(1):61-7. doi: 10.1016/j.cyto.2010.12.017. Epub 2011 Jan 26. Cytokine. 2011. PMID: 21266308 Free PMC article.

3

Molecular mechanisms of Sonic hedgehog mutant effects in holoprosencephaly.

Maity T, Fuse N, Beachy PA. Maity T, et al. Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17026-31. doi: 10.1073/pnas.0507848102. Epub 2005 Nov 10. Proc Natl Acad Sci U S A. 2005. PMID: 16282375 Free PMC article.

4

Febrile-range temperature modifies cytokine gene expression in LPS-stimulated macrophages by differentially modifying NF-{kappa}B recruitment to cytokine gene promoters.

Cooper ZA, Ghosh A, Gupta A, Maity T, Benjamin IJ, Vogel SN, Hasday JD, Singh IS. Cooper ZA, et al. Am J Physiol Cell Physiol. 2010 Jan;298(1):C171-81. doi: 10.1152/ajpcell.00346.2009. Epub 2009 Oct 21. Am J Physiol Cell Physiol. 2010. PMID: 19846753 Free PMC article.

5

Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release.

Gupta A, Cooper ZA, Tulapurkar ME, Potla R, Maity T, Hasday JD, Singh IS. Gupta A, et al. J Biol Chem. 2013 Jan 25;288(4):2756-66. doi: 10.1074/jbc.M112.427336. Epub 2012 Dec 4. J Biol Chem. 2013. PMID: 23212905 Free PMC article.

6

Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.

Zhang X, Belkina N, Jacob HK, Maity T, Biswas R, Venugopalan A, Shaw PG, Kim MS, Chaerkady R, Pandey A, Guha U. Zhang X, et al. Proteomics. 2015 Jan;15(2-3):340-55. doi: 10.1002/pmic.201400315. Proteomics. 2015. PMID: 25404012 Free PMC article.

7

Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.

Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U. Maity TK, et al. Cancer Discov. 2015 May;5(5):534-49. doi: 10.1158/2159-8290.CD-14-0750. Epub 2015 Mar 3. Cancer Discov. 2015. PMID: 25735773 Free PMC article.

8

Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.

Biswas R, Gao S, Cultraro CM, Maity TK, Venugopalan A, Abdullaev Z, Shaytan AK, Carter CA, Thomas A, Rajan A, Song Y, Pitts S, Chen K, Bass S, Boland J, Hanada KI, Chen J, Meltzer PS, Panchenko AR, Yang JC, Pack S, Giaccone G, Schrump DS, Khan J, Guha U. Biswas R, et al. Among authors: maity tk. Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001263. doi: 10.1101/mcs.a001263. Cold Spring Harb Mol Case Stud. 2016. PMID: 27900369 Free PMC article.

9

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response.

Zhang X, Maity T, Kashyap MK, Bansal M, Venugopalan A, Singh S, Awasthi S, Marimuthu A, Charles Jacob HK, Belkina N, Pitts S, Cultraro CM, Gao S, Kirkali G, Biswas R, Chaerkady R, Califano A, Pandey A, Guha U. Zhang X, et al. Mol Cell Proteomics. 2017 May;16(5):891-910. doi: 10.1074/mcp.M117.067439. Epub 2017 Mar 22. Mol Cell Proteomics. 2017. PMID: 28331001 Free PMC article.

10

Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.

Awasthi S, Maity T, Oyler BL, Qi Y, Zhang X, Goodlett DR, Guha U. Awasthi S, et al. J Proteomics. 2018 Oct 30;189:48-59. doi: 10.1016/j.jprot.2018.04.005. Epub 2018 Apr 13. J Proteomics. 2018. PMID: 29660496 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters